The success of Pfizer Inc.’s Covid-19 vaccine trial may help persuade more people to get inoculated amid a surge in new coronavirus cases, according to Anthony Fauci, the top U.S. infectious-disease doctor. That could be a key factor in overcoming reluctance to take pandemic vaccines that have been developed at top speed. The U.S. may begin offering the vaccine to priority groups at the end of December, Fauci said. “And if that is really comparable to what we saw with the Pfizer trial, we’ll now have two highly effective vaccines," he said. The duration of their protection, or that of any Covid-19 vaccine, isn’t yet known, Fauci said.

Source: Mint November 15, 2020 01:07 UTC